AI in Clinical Trials Market worth $2.74 billion by 2030
The AI in clinical trials market refers to the utilization of artificial intelligence-based tools to improve the different phases as well as steps of clinical research process activity such as trial development, enrolment of patients, data management and analysis and therapeutic monitoring. Al assists in accomplishing such tasks by automating the collection of data, enhancing the efficiency of patient matching and improving prediction of outcomes of trials which in turn helps in reducing the timeline and cost associated with these processes. Market Overview The integration of Artificial Intelligence (AI) into clinical trials is revolutionizing the drug development process. AI offers the potential to accelerate timelines, reduce costs, and improve the overall efficiency and accuracy of clinical research. From patient recruitment and data analysis to predictive modeling and risk assessment, AI is transforming various aspects of clinical trials. Market Size and Forecast 20...